地拉罗司是否进入医保？

(Enrig) Entering health insurance? Deferasirox (Enriga) is an iron chelator product developed by the Swiss pharmaceutical company Novartis. It is the first oral iron anthelmintic approved by the US FDA for routine use. It is approved for use in patients ≥2 years old with chronic iron overload caused by blood transfusion. Severe aplastic anemia has an acute onset and rapid progression, with fever and bleeding. Especially in extremely severe aplastic anemia, the granulocytes are very low, the natural survival period is short, and the mortality rate is high. This disease means that the hematopoietic function has been severely damaged and normal hematopoiesis can no longer be produced. Deferasirox dispersible tablets (Enrige) are commonly used drugs for the treatment of such diseases.

At present, Deferasirox (Enrego) has also been launched in China. The domestic specification of Deferasirox (Enrego) is 125mg/tablet*28 tablets/bottle (box), and the price is 2330$, which is not cheap. Although it has been marketed in China, it is not included in the medical insurance catalog, so patients cannot be reimbursed by medical insurance after purchasing the drug. If patients need to take this drug for long-term treatment, the price will be a big burden.

CIPLA Pharmaceuticals, one of the well-known pharmaceutical companies in India, has launched a generic version of Deferasirox (Enrega), with a specification of 500mg*30 tablets/box and a price equivalent to RMB only about $500. The price is much lower than the original drug. For patients who need to take this drug for long-term treatment, the price of the Indian generic version of Deferasirox (Enrige) is more acceptable.

Although it is a generic drug, its efficacy is almost the same as that of the original drug, it has the same effect, and the price is more affordable and cost-effective, which is why it has become the choice of many patients. Patients can choose to go abroad to purchase Deferasirox (Enrige) by themselves, but it is not recommended to purchase the drug through purchasing agents. Since the exchange rate floating price is not fixed, if patients want to know the specific price of the drug, or want to purchase it overseas (Enrige), they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).

Recommended related hot articles: /newsDetail/75850.html